- Prescribing Considerations:
• Pregnancy – limited treatment options. Avoid topical retinoids and oral tetracyclines and consider for patients of childbearing potential as effective contraception may be needed.
• Patient preference – frequency of application, potential for photosensitivity, skin irritation, bleaching of hair and fabrics etc.
• To reduce the risk of skin irritation, start topical treatments e.g. benzoyl peroxide or retinoids, with alternate day or short-contact application (e.g. wash off after an hour).
• Patients should be advised on sun protection if using oral tetracyclines and topical retinoids as both increase photosensitivity.
Initial Primary Care Management
Please see link to C&W APC guideline for management advice for Acne vulgaris: RD065-Primary Care Acne Pathway.pdf
| Mild
1 or more of: |
→ | Offer a 12-week course of one of the following, apply once daily in the evening:
If mainly comedonal acne- • Topical 0.1% adapalene OR
For combination acne Topical 0.1% or 0.3% adapalene with 2.5% benzoyl peroxide (Epiduo®) OR OR OR
|
| ↓ | ||
| Moderate To Severe
• 35 or more inflammatory lesions |
→ | Offer a 12-week course of one of the following:
Topical 0.1% or 0.3% adapalene with 2.5% benzoyl peroxide (Epiduo®) WITH oral antibiotic Topical 0.025% tretinoin with 1% clindamycin (Treclin®) WITH oral antibiotic Topical azelaic acid 15% (Finacea®) or 20% (Skinoren®) WITH oral antibiotic Topical 0.005% trifarotene (Aklief®) WITH oral antibiotic Topical 1% clascoterone (Winlevi®) WITH oral antibiotic Do not use monotherapy with a topical or oral antibiotic
Antibiotic Choices (> 12 years and over) Oral lymecycline 408mg once daily Oral doxycycline 100mg once daily If tetracyclines contraindicated, consider oral erythromycin 500mg twice daily
If further advice needed, refer to specialist dermatology services |
| ↓ | ||
| → | Combined oral contraceptives (if not contraindicated) in combination with topical agents can be considered as an alternative to systemic antibiotics in women.
• Co-cyprindiol or other ethinylestradiol/cyproterone acetate-containing products may be considered where other treatments have failed Discontinue 3 months after acne has been controlled. |
|
| Maintainence | → |
|
| Specialist Referral Criteria |
→ |
Mild to moderate acne that hasn’t responded to 2 completed courses of treatment OR moderate to severe acne that hasn’t responded to previous treatment containing oral antibiotic.
• Refer to a consultant-led dermatology team or GPwER if patient presents with any of the following: o Nodulo-cystic acne or acne conglobata acne with scarring (refer at presentation and commence treatment as below) o Acne with persistent pigmentary changes. o If acne (any severity) or related scarring is contributing to psychological distress or mental health disorder.
o Diagnostic difficulty (uncommon) o Severe variant of acne e.g. acne fulminans – very rare severe inflammatory acne systemically unwell (fever, malaise and joint symptoms) urgent dermatology referral within 24hrs If patient is referred to dermatology at initial presentation e.g. acne conglobata, nodulo-cystic acne – Commence topical adapalene and benzoyl peroxide (Epiduo) OR topical azelaic acid,
|
| Skincare advice
|
Avoid over-cleaning the skin (may cause dryness/irritation)
Use a non-alkaline synthetic detergent twice a day on acne prone skin Avoid oil based comedogenic skin care products Persistent picking or scratching can increase risk of scarring Maintain a healthy diet |
|

Leave feedback
You must be logged in to post a comment.